Description :
Investors are always looking for that next big thing to put their money into. The medical field is rife with such opportunities, thanks to ongoing advancements that are making it possible for us to treat all sorts of things that were previously out of reach. If you are an orthopedist, aesthetic practitioner or GP, you might want to consider your own local investment in the emerging area of stem cell therapy.
Take 'local investment' to mean investing in your own practice. Put the time and effort into PRP and stem cell training by attending courses that will teach you how PRP and stem cell therapies work and the procedures necessary to implement them. Apex Biologix, a company located in Murray, Utah, is one example of a competent trading provider you could work with. They have already assisted more than 200 clinics in establishing regenerative medicine services.
Worldwide Market Expected to Boom
There would certainly be nothing wrong with investing in a company directly involved in the manufacture and sale of regenerative medicine products. In fact, such investments would be rather wise. Recent numbers suggest the global market for regenerative medicine will reach nearly $39 billion by 2021. The expected rate of growth should be just under 24%.
Those numbers are pretty impressive by any standard. But here's what you need to know as a doctor: a significant portion of that $39 billion will not be realized through investments in the industry's corporate players. Rather, it will be spent by patients looking for regenerative medicine for wound care, orthopedic treatments, and aesthetic medicine. You can get your share of the action by undergoing training and then adding regenerative medicine to your own practice.
Investing in the Future of Medicine
An analysis of the regenerative medicine market suggests that investment is being driven by an expectation that the future of things such as PRP and stem cell therapy looks good. When investors spot something in which they see a lot of potential, they are not afraid to put their money behind it. And wherever the markets go, reality often follows.
With that said, the strong investment in regenerative medicine suggests that anticipated growth will become a reality. Institutional investors will put money into the companies producing products and therapies, companies like Apex Biologix will invest their resources in training doctors and supplying them with equipment, and patients will invest in the actual procedures that will help them live healthier lives.
How to Get Trained
Doctors looking to invest in regenerative medicine can take a series of training courses depending on the kinds of services they want to offer. Continuing with Apex Biologix as the example, they offer training courses for both PRP and stem cell therapy. Their courses cover aesthetic medicine, orthopedics, and marketing regenerative medicine services to clients.
Their longest training course is a two-day affair held at various locations around the country. That two-day course centers around stem cell therapy for orthopedic applications. Apex Biologix also offers a one-day training course in PRP therapy for aesthetic medicine. Both courses include additional training for marketing regenerative medicine procedures.
Conclusion
As much as we don't like to talk about it, medicine is a business that requires a certain level of revenue to keep the lights on and the doors open. It is clear that institutional investors are rather optimistic about the future of regenerative medicine, so much so that they are willing to put their money behind it. Doctors can invest in their own practices by receiving training and then adding regenerative medicine to what they currently offer patients.
NEXT ARTICLE RECOMMENDATION: An Overview of the Human Genome Project
Jump right to the post by clicking the link above, and please don't forget to share your thoughts in the comments!
*by andreascy*
